CCND1 and non-small cell lung carcinoma: As shown in Figure 5, the protein expressions of β-catenin and P-GSK3β in NSCLC cells treated with Afatinib were lower than those in the DDP+PEM group or saline group, and the protein expression of Cyclin D1 decreased.